Literature DB >> 19223488

Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation.

Hui-Ju Wen1, Veenu Minhas1, Charles Wood1.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) replication and transcription activator (RTA) is well established as a key transcriptional activator that regulates the KSHV life cycle from latency to lytic replication. It is expressed immediately after infection and activates a number of viral genes leading to virus replication. The RTA-responsive element (RRE) in the RTA target gene promoters is critical for RTA to mediate this transactivation. A number of non-conserved RREs have been identified in various RTA-responsive promoters, and AT-rich sequences have been proposed to serve as RTA targets, but no consensus RRE sequence has been identified so far. Two non-conserved RREs (RRE1 and RRE2) containing AT-rich sequences have been identified previously in the promoter of one of the KSHV lytic genes, ORF57, which can be strongly activated by RTA. Based on homology with the consensus sequence of the Epstein-Barr virus Rta RRE, this study identified a third RTA-responsive element (RRE3) in the ORF57 promoter. This RRE comprised a GC-rich sequence that could bind RTA both in vitro and in vivo, and plays a role in RTA-mediated transactivation of the ORF57 promoter. The presence of two of the three RREs in close proximity to each other was required for optimal RTA-mediated transactivation of the ORF57 promoter, even though the presence of only one RRE is needed for RTA binding. These results suggest that the ability of RTA to mediate transcriptional activation is distinct from its ability to bind to its target elements.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223488      PMCID: PMC2889438          DOI: 10.1099/vir.2008.006817-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  42 in total

1.  Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Masahiro Fujimuro; Jianchao Zong; S Diane Hayward; Gary S Hayward
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

Authors:  Yuying Liang; Jean Chang; Stephen J Lynch; David M Lukac; Don Ganem
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

3.  Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression.

Authors:  S Sakakibara; K Ueda; J Chen; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer.

Authors:  Wei Bu; Kyla Driscoll Carroll; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

5.  Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation.

Authors:  S Wang; S Liu; M H Wu; Y Geng; C Wood
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence.

Authors:  S Wang; S Liu; M Wu; Y Geng; C Wood
Journal:  Arch Virol       Date:  2001-07       Impact factor: 2.574

7.  Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.

Authors:  C Rivas; A E Thlick; C Parravicini; P S Moore; Y Chang
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.

Authors:  G Miller; L Heston; E Grogan; L Gradoville; M Rigsby; R Sun; D Shedd; V M Kushnaryov; S Grossberg; Y Chang
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus.

Authors:  Hongyu Deng; Arthur Young; Ren Sun
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

10.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sun; S F Lin; L Gradoville; Y Yuan; F Zhu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

View more
  8 in total

1.  Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL.

Authors:  Diana Palmeri; Kyla Driscoll Carroll; Olga Gonzalez-Lopez; David M Lukac
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

2.  Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.

Authors:  Brian S Wakeman; Yoshihiro Izumiya; Samuel H Speck
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Replication and transcription activator (RTA) of murine gammaherpesvirus 68 binds to an RTA-responsive element and activates the expression of ORF18.

Authors:  Yun Hong; Jing Qi; Danyang Gong; Chuanhui Han; Hongyu Deng
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

4.  Number of and distance between response elements in Kaposi's sarcoma-associated herpesvirus ORF57 promoter influence its activation by replication and transcription activator and its repression by interferon regulatory factor 7.

Authors:  Xiao-Hui Liu; Yue-Qi Liu; Xiao-Yong Shi; Ying Wang; Yun-Qi Geng; Jin-Zhong Wang
Journal:  Arch Virol       Date:  2009-12-29       Impact factor: 2.574

5.  Upregulation of cellular Bcl-2 by the KSHV encoded RTA promotes virion production.

Authors:  Jianming Gao; Qiliang Cai; Jie Lu; Hem Chandra Jha; Erle S Robertson
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

6.  KSHV Rta Promoter Specification and Viral Reactivation.

Authors:  Jonathan Guito; David M Lukac
Journal:  Front Microbiol       Date:  2012-02-14       Impact factor: 5.640

Review 7.  KSHV ORF57, a protein of many faces.

Authors:  Vladimir Majerciak; Zhi-Ming Zheng
Journal:  Viruses       Date:  2015-02-10       Impact factor: 5.048

Review 8.  Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.

Authors:  Kawalpreet K Aneja; Yan Yuan
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.